Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia

Cancer Research
Jan CoolsD Gary Gilliland

Abstract

Mutations in the receptor tyrosine kinase FLT3 occur frequently in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Small molecules that selectively inhibit FLT3 kinase activity induce apoptosis in blasts from AML patients with FLT3 mutations and prolong survival in animal models of FLT3-induced myeloproliferative disease. A spectrum of structurally different small molecules with activity against FLT3 have been described, and their efficacy for treatment of AML and ALL is now being investigated in clinical trials. Here, we describe the results of an in vitro screen designed to identify mutations in the ATP-binding pocket of FLT3 that confer resistance to tyrosine kinase inhibitors. Mutations at four different positions (Ala-627, Asn-676, Phe-691, and Gly-697) were identified that confer varying degrees of resistance to PKC412, SU5614, or K-252a. FLT3 proteins mutated at Ala-627, Asn-676, or Phe-691 remained sensitive to higher concentrations of the inhibitors, but the G697R mutation conferred high-level resistance to each of these inhibitors as well as to six additional experimental inhibitors. These data provide insights into potential mechanisms of acquired resistance of FLT3 to small molecul...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G C RiceD W Leung
Mar 1, 1990·Journal of Molecular Graphics·G Vriend
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Sep 3, 2003·Nature Reviews. Cancer·Derek L Stirewalt, Jerald P Radich
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers

❮ Previous
Next ❯

Citations

Jan 5, 2006·Annals of Hematology·Michael A Morgan, Christoph W M Reuter
Apr 25, 2013·International Journal of Hematology·Michael R Grunwald, Mark J Levis
May 5, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jan CoolsPeter Marynen
Dec 7, 2011·Journal of Chemical Information and Modeling·Kuei-Chung ShihNai-Wan Hsiao
Jul 28, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Timothy KottkeRichard Vile
Jan 15, 2010·Nature·Jianming ZhangNathanael S Gray
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Jul 25, 2009·Nature Reviews. Drug Discovery·Pasi A JänneJeff Settleman
Jan 16, 2009·Blood·Frank BreitenbuecherThomas Fischer
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nikhil WagleLevi A Garraway
Sep 9, 2005·International Journal of Hematology·Yiwen Li, Zhenping Zhu
Sep 9, 2005·International Journal of Hematology·Mark Levis, Donald Small
Apr 1, 2014·Current Hematologic Malignancy Reports·Akshay Sudhindra, Catherine Choy Smith
Sep 3, 2010·Molecular Cancer Therapeutics·Ellen WeisbergJames D Griffin
Dec 5, 2008·Leukemia & Lymphoma·Shahram MoriFarhad Ravandi
Feb 18, 2011·Expert Opinion on Therapeutic Patents·Jongkook LeeSun-Young Han
Dec 1, 2008·Expert Review of Hematology·Khaled el-ShamiB Douglas Smith
Mar 1, 2006·Expert Opinion on Emerging Drugs·Lara TickenbrockHubert Serve
Sep 8, 2011·Expert Opinion on Investigational Drugs·Steven Knapper
Aug 13, 2009·Expert Opinion on Investigational Drugs·Celalettin UstunKapil N Bhalla
Feb 20, 2016·Annals of Hematology·Kezhi HuangZhixiong Li
Nov 23, 2013·Nucleic Acids Research·Chu QinYu Zong Chen
Jan 24, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·S Haihua Chu, Donald Small

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.